SlideShare a Scribd company logo
CORONAVIRUS
(COVID-19/SARS-CoV-2)
TECHNICAL JARGON BROKEN DOWN FOR
NON-HEALTH/SCIENCE INDIVIDUALS TO
COMPREHEND
PRESENTED BY: DR. MICHELLE STAUFFER, PT, DPT
Disclosures/Disclaimer
 I have no disclosures. My company is not affiliated with this content.
 The information provided is meant solely as EDUCATIONAL.
 The information provided is NOT intended to replace seeking medical,
professional care for individualized and specific healthcare needs.
 The information provided is based off one individual’s review of some, but
not all, literature at the present time of presentation production.
 Research/evidence related to coronavirus is constantly evolving and
information is subject to change.
Who am I?
 Doctor of physical therapy – since 2017
 Graduate of University of Colorado Anschutz Medical Campus
 Ranked #13 in US
 Passionate about the cardiopulmonary system
 Work in subacute rehabilitation
 Aka skilled-nursing facility
Objectives
 Discuss background
 Discuss known transmission and protection
 Discuss virus entry and molecular effects of body
 Explain comorbidities at risk
 Generic treatment aides
Background
 Originated in Wuhan, China
 Suspected animal origin
 alpha, beta  bats
 known for human illness
 gamma, delta  avian/pig
 New suspicions lab origin
 Timeline of knowledge:
 First hospitalization in China 11/19’
 WHO informed of “pneumonia of unknown etiology” 12/19’
 Secretary of HHS declared “public health emergency” 1/31/20
 First declared US case 2/26/20
 WHO declared pandemic 3/11/20
 Trump declared “National Emergency” 3/13/20
Transmission
 Respiratory/salivary droplets
 Cough
 Sneeze
 Spoken word
 Incubation 2-12 days
 Typical 2-3 before symptoms
 Shedding up to 37 days
Self-protection:
 Contact precaution:
 Cover areas that may physically touch
pathogen
 Droplet precaution:
 Cover areas that a drop may touch
 Airborne precaution:
 Cover areas open to air particles
 Smaller than droplet
Virus Entry to Body
ACE2 receptor locations in humans:
 Oral and nasal mucosa
 Nasopharynx
 Lung
 Stomach
 Intestine
 Skin
 Lymph nodes
 Thymus
 Bone marrow
 Spleen
 Liver
 Kidney
 Brain
ACE2 Receptor
Molecular Effects on Body
Molecules Creating Symptoms
Comorbidities Increasing Risk
INTERNAL:
 Older age
 DIABETES
 Cardiac issues
 Lung issues
 Kidney disease
 Liver disease
 Autoimmune diseases
EXTERNAL:
 Low income/poverty
 Rural living
 Developing nation
 Social support
 Family/roommates
Treatment …
 Best option TBD
 No vaccine as of yet
 No “gold standard” test
 Clinical trials underway
For mild cases:
 Vital monitoring (temp, HR)
 Hydration/electrolytes
 Light exercise (1MET or RPE 1-3/10)
 Adequate rest
 Anti-inflammatory diet
 Scrubbing of hands 15-20sec
Fun fact: coronaviruses do not like *Heat and UV rays* hence the
reason for “flu season” occurring in Winter not Summer.
Why Light Exercise v My Normal?
 Starting with elevated heart rate and likely impaired lung function
 Impaired oxygenation to body
 Abnormal heart rhythm
 Normal strength training (60-80% max effort) works to breakdown muscle
systems
 Spreading work capacity to heal body
 Inc/restart inflammatory response
 Work lower extremity vs upper extremity
 Less HR and BP changes
QUESTIONS
Citations
1. Coronavirus | Human Coronavirus Types | CDC. https://www.cdc.gov/coronavirus/types.html. Published February 27, 2020. Accessed April 18, 2020.
2. Fehr AR, Perlman S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Coronaviruses. 2015;1282:1-23. doi:10.1007/978-1-4939-2438-7_1
3. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls
Publishing; 2020. http://www.ncbi.nlm.nih.gov/books/NBK554776/.
4. Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak. The White House.
https://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/. Accessed
April 18, 2020. 1.
5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.
2020. 1.
6. Coronavirus COVID-19 (SARS-CoV-2) | Johns Hopkins ABX Guide.
https://www.hopkinsguides.com/hopkins/.//view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_?refer=true. Accessed April 18, 2020. 1.
7. Isolation Precautions | Guidelines Library | Infection Control | CDC. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html. Published July 22, 2019.
Accessed April 18, 2020. 1.
8. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in
understanding SARS pathogenesis. The Journal of Pathology. 2004;203(2):631-637. doi:10.1002/path.15701.
9. The Renin-Angiotensin-Aldosterone-System - Renin Release - Angiotensin II Production. TeachMePhysiology. https://teachmephysiology.com/urinary-
system/regulation/the-renin-angiotensin-aldosterone-system/. Accessed April 18, 2020. 1.
10. Twig Interactive L http://www twiginteractive com. Programs. Tarix Orphan. http://www.tarixorphan.com/programs/. Accessed April 18, 2020.
11. (422) Vital Signs, Oxygen, & Exercise Prescription. How are these impacted by COVID-19 By Ellen Hillegass - YouTube.
https://www.youtube.com/watch?v=lj716KWNcig. Accessed April 18, 2020. 1.
12. Papinska AM, Soto M, Meeks CJ, Rodgers KE. Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes
(db/db) by reducing oxidative stress, inflammation and pathological remodeling. Pharmacol Res. 2016;107:372-380. doi:10.1016/j.phrs.2016.02.0261.
13. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. New
England Journal of Medicine. 2020;0(0):null. doi:10.1056/NEJMsr2005760

More Related Content

What's hot

COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING INNOVATIVE APPR...
COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING  INNOVATIVE APPR...COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING  INNOVATIVE APPR...
COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING INNOVATIVE APPR...
EMMANUEL AKOMANIN ASIAMAH
 
Corona virus (covid 19) by Gaurav Jain
Corona virus (covid 19) by Gaurav JainCorona virus (covid 19) by Gaurav Jain
Corona virus (covid 19) by Gaurav Jain
Gaurav Jain
 
Covid 19 (novel corona virus)
Covid 19 (novel corona virus)Covid 19 (novel corona virus)
Covid 19 (novel corona virus)
RajatThakur57
 
Corona virus
Corona virusCorona virus
Corona virus
Sansar Babu Tiwari
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overview
Makrani Shaharukh
 
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
ChiagozieHenry1
 
Covid 19 presentation
Covid 19  presentationCovid 19  presentation
Covid 19 presentation
Nurses Professional Education
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
tulu2015
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19
Avinandan Jana
 
Corona virus disease 2019
Corona virus disease 2019Corona virus disease 2019
Corona virus disease 2019
Pinky San Jose Borja
 
Coronavirus (covid 19)
Coronavirus (covid 19)Coronavirus (covid 19)
Coronavirus (covid 19)
DHUMAL KULDIP S
 
Coronavirus Disease (COVID- 19)
Coronavirus Disease (COVID- 19)Coronavirus Disease (COVID- 19)
Coronavirus Disease (COVID- 19)
Saurabh Kedar
 
Ppt on corona
Ppt on coronaPpt on corona
Ppt on corona
nehabhosale18
 
Coronavirus presentation
Coronavirus presentationCoronavirus presentation
Coronavirus presentation
DanVulcanescu
 
Which respiratory viral disease is worse: SARS or COVID-19?
Which respiratory viral disease is worse: SARS or COVID-19?Which respiratory viral disease is worse: SARS or COVID-19?
Which respiratory viral disease is worse: SARS or COVID-19?
Kevin KF Ng
 
Covid 19 and other coronavirus airborne indoor and outdoor transmission sta...
Covid  19 and other coronavirus  airborne indoor and outdoor transmission sta...Covid  19 and other coronavirus  airborne indoor and outdoor transmission sta...
Covid 19 and other coronavirus airborne indoor and outdoor transmission sta...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Haider Ali Malik
 
Corona virus 2019 nCoV
Corona virus 2019 nCoVCorona virus 2019 nCoV
Corona virus 2019 nCoV
pankaj kushwaha
 
Covid19 by likhit
Covid19  by likhitCovid19  by likhit
Covid19 by likhit
Likhit Akotkar
 

What's hot (20)

COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING INNOVATIVE APPR...
COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING  INNOVATIVE APPR...COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING  INNOVATIVE APPR...
COVID - 1 9 PANDEMIC AND THE FACE MASK CONTROVERSY: ADOPTING INNOVATIVE APPR...
 
Corona virus (covid 19) by Gaurav Jain
Corona virus (covid 19) by Gaurav JainCorona virus (covid 19) by Gaurav Jain
Corona virus (covid 19) by Gaurav Jain
 
Covid 19 (novel corona virus)
Covid 19 (novel corona virus)Covid 19 (novel corona virus)
Covid 19 (novel corona virus)
 
Corona virus
Corona virusCorona virus
Corona virus
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overview
 
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
 
Covid 19 pandemic
Covid 19 pandemicCovid 19 pandemic
Covid 19 pandemic
 
Covid 19 presentation
Covid 19  presentationCovid 19  presentation
Covid 19 presentation
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19
 
Corona virus disease 2019
Corona virus disease 2019Corona virus disease 2019
Corona virus disease 2019
 
Coronavirus (covid 19)
Coronavirus (covid 19)Coronavirus (covid 19)
Coronavirus (covid 19)
 
Coronavirus Disease (COVID- 19)
Coronavirus Disease (COVID- 19)Coronavirus Disease (COVID- 19)
Coronavirus Disease (COVID- 19)
 
Ppt on corona
Ppt on coronaPpt on corona
Ppt on corona
 
Coronavirus presentation
Coronavirus presentationCoronavirus presentation
Coronavirus presentation
 
Which respiratory viral disease is worse: SARS or COVID-19?
Which respiratory viral disease is worse: SARS or COVID-19?Which respiratory viral disease is worse: SARS or COVID-19?
Which respiratory viral disease is worse: SARS or COVID-19?
 
Covid 19 and other coronavirus airborne indoor and outdoor transmission sta...
Covid  19 and other coronavirus  airborne indoor and outdoor transmission sta...Covid  19 and other coronavirus  airborne indoor and outdoor transmission sta...
Covid 19 and other coronavirus airborne indoor and outdoor transmission sta...
 
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
 
Corona virus 2019 nCoV
Corona virus 2019 nCoVCorona virus 2019 nCoV
Corona virus 2019 nCoV
 
Covid19 by likhit
Covid19  by likhitCovid19  by likhit
Covid19 by likhit
 

Similar to Coronavirus 2019

Covid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores MalpartidaCovid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
 
7th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 20207th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 2020
Institute for Clinical Research (ICR)
 
The coronavirus’s survival mechanism is what makes it so dangerous
The coronavirus’s survival mechanism is what makes it so dangerousThe coronavirus’s survival mechanism is what makes it so dangerous
The coronavirus’s survival mechanism is what makes it so dangerous
EduardoClemente15
 
COVID-19
COVID-19COVID-19
COVID-19
BryanJohnson149
 
COVID-19: An Approach for EMS
COVID-19: An Approach for EMSCOVID-19: An Approach for EMS
COVID-19: An Approach for EMS
BryanJohnson149
 
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First EditionHA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
Health Advances
 
Influenza Vaccine Case Study
Influenza Vaccine Case StudyInfluenza Vaccine Case Study
Influenza Vaccine Case Study
Gina Alfaro
 
Covid-19: what is our learning?
Covid-19: what is our learning?Covid-19: what is our learning?
Covid-19: what is our learning?
Turacoz Healthcare Solutions
 
CoronaVirus - Isma Zubair (COVID19).pptx
CoronaVirus - Isma Zubair (COVID19).pptxCoronaVirus - Isma Zubair (COVID19).pptx
CoronaVirus - Isma Zubair (COVID19).pptx
IsmaZubair
 
Covid 19 and the cardiovascular system implications for risk assessment dia...
Covid 19 and the cardiovascular system  implications for risk assessment  dia...Covid 19 and the cardiovascular system  implications for risk assessment  dia...
Covid 19 and the cardiovascular system implications for risk assessment dia...
Ramachandra Barik
 
Don’t panic the comprehensive ars technica guide to the coronavirus [updated...
Don’t panic  the comprehensive ars technica guide to the coronavirus [updated...Don’t panic  the comprehensive ars technica guide to the coronavirus [updated...
Don’t panic the comprehensive ars technica guide to the coronavirus [updated...
RohitRajaram2
 
Recent advance in hiv treatment 1
Recent advance in hiv treatment 1Recent advance in hiv treatment 1
Recent advance in hiv treatment 1
Chetkant Bhusal
 
COVID 19 A Scoping Review
COVID 19 A Scoping ReviewCOVID 19 A Scoping Review
COVID 19 A Scoping Review
ijtsrd
 
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
Asheesh Kumar Mishra
 
Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...
BARRY STANLEY 2 fasd
 
Innovative Solutions to Combat Spread & Management of Covid-19
Innovative Solutions to Combat Spread & Management of Covid-19Innovative Solutions to Combat Spread & Management of Covid-19
Innovative Solutions to Combat Spread & Management of Covid-19
Sidharth Mehta
 
Novel corona virus COVID-19 Management and Emerging Treatment
Novel corona virus COVID-19 Management and Emerging Treatment Novel corona virus COVID-19 Management and Emerging Treatment
Novel corona virus COVID-19 Management and Emerging Treatment
farah al souheil
 
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
DrHeena tiwari
 
Coronavirus07
Coronavirus07Coronavirus07
Coronavirus07
Rodney Jetton
 
Public health disease pandemics
Public health disease pandemicsPublic health disease pandemics
Public health disease pandemics
jharm35
 

Similar to Coronavirus 2019 (20)

Covid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores MalpartidaCovid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores Malpartida
 
7th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 20207th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 2020
 
The coronavirus’s survival mechanism is what makes it so dangerous
The coronavirus’s survival mechanism is what makes it so dangerousThe coronavirus’s survival mechanism is what makes it so dangerous
The coronavirus’s survival mechanism is what makes it so dangerous
 
COVID-19
COVID-19COVID-19
COVID-19
 
COVID-19: An Approach for EMS
COVID-19: An Approach for EMSCOVID-19: An Approach for EMS
COVID-19: An Approach for EMS
 
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First EditionHA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
HA101: Demystifying SARS-CoV-2 Testing for COVID-19-First Edition
 
Influenza Vaccine Case Study
Influenza Vaccine Case StudyInfluenza Vaccine Case Study
Influenza Vaccine Case Study
 
Covid-19: what is our learning?
Covid-19: what is our learning?Covid-19: what is our learning?
Covid-19: what is our learning?
 
CoronaVirus - Isma Zubair (COVID19).pptx
CoronaVirus - Isma Zubair (COVID19).pptxCoronaVirus - Isma Zubair (COVID19).pptx
CoronaVirus - Isma Zubair (COVID19).pptx
 
Covid 19 and the cardiovascular system implications for risk assessment dia...
Covid 19 and the cardiovascular system  implications for risk assessment  dia...Covid 19 and the cardiovascular system  implications for risk assessment  dia...
Covid 19 and the cardiovascular system implications for risk assessment dia...
 
Don’t panic the comprehensive ars technica guide to the coronavirus [updated...
Don’t panic  the comprehensive ars technica guide to the coronavirus [updated...Don’t panic  the comprehensive ars technica guide to the coronavirus [updated...
Don’t panic the comprehensive ars technica guide to the coronavirus [updated...
 
Recent advance in hiv treatment 1
Recent advance in hiv treatment 1Recent advance in hiv treatment 1
Recent advance in hiv treatment 1
 
COVID 19 A Scoping Review
COVID 19 A Scoping ReviewCOVID 19 A Scoping Review
COVID 19 A Scoping Review
 
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
802 presentation asheesh kumar mishra_dr. shakuntala misra national rehabilit...
 
Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...
 
Innovative Solutions to Combat Spread & Management of Covid-19
Innovative Solutions to Combat Spread & Management of Covid-19Innovative Solutions to Combat Spread & Management of Covid-19
Innovative Solutions to Combat Spread & Management of Covid-19
 
Novel corona virus COVID-19 Management and Emerging Treatment
Novel corona virus COVID-19 Management and Emerging Treatment Novel corona virus COVID-19 Management and Emerging Treatment
Novel corona virus COVID-19 Management and Emerging Treatment
 
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
 
Coronavirus07
Coronavirus07Coronavirus07
Coronavirus07
 
Public health disease pandemics
Public health disease pandemicsPublic health disease pandemics
Public health disease pandemics
 

Recently uploaded

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 

Recently uploaded (20)

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 

Coronavirus 2019

  • 1. CORONAVIRUS (COVID-19/SARS-CoV-2) TECHNICAL JARGON BROKEN DOWN FOR NON-HEALTH/SCIENCE INDIVIDUALS TO COMPREHEND PRESENTED BY: DR. MICHELLE STAUFFER, PT, DPT
  • 2. Disclosures/Disclaimer  I have no disclosures. My company is not affiliated with this content.  The information provided is meant solely as EDUCATIONAL.  The information provided is NOT intended to replace seeking medical, professional care for individualized and specific healthcare needs.  The information provided is based off one individual’s review of some, but not all, literature at the present time of presentation production.  Research/evidence related to coronavirus is constantly evolving and information is subject to change.
  • 3. Who am I?  Doctor of physical therapy – since 2017  Graduate of University of Colorado Anschutz Medical Campus  Ranked #13 in US  Passionate about the cardiopulmonary system  Work in subacute rehabilitation  Aka skilled-nursing facility
  • 4. Objectives  Discuss background  Discuss known transmission and protection  Discuss virus entry and molecular effects of body  Explain comorbidities at risk  Generic treatment aides
  • 5. Background  Originated in Wuhan, China  Suspected animal origin  alpha, beta  bats  known for human illness  gamma, delta  avian/pig  New suspicions lab origin  Timeline of knowledge:  First hospitalization in China 11/19’  WHO informed of “pneumonia of unknown etiology” 12/19’  Secretary of HHS declared “public health emergency” 1/31/20  First declared US case 2/26/20  WHO declared pandemic 3/11/20  Trump declared “National Emergency” 3/13/20
  • 6. Transmission  Respiratory/salivary droplets  Cough  Sneeze  Spoken word  Incubation 2-12 days  Typical 2-3 before symptoms  Shedding up to 37 days Self-protection:  Contact precaution:  Cover areas that may physically touch pathogen  Droplet precaution:  Cover areas that a drop may touch  Airborne precaution:  Cover areas open to air particles  Smaller than droplet
  • 7. Virus Entry to Body ACE2 receptor locations in humans:  Oral and nasal mucosa  Nasopharynx  Lung  Stomach  Intestine  Skin  Lymph nodes  Thymus  Bone marrow  Spleen  Liver  Kidney  Brain ACE2 Receptor
  • 10. Comorbidities Increasing Risk INTERNAL:  Older age  DIABETES  Cardiac issues  Lung issues  Kidney disease  Liver disease  Autoimmune diseases EXTERNAL:  Low income/poverty  Rural living  Developing nation  Social support  Family/roommates
  • 11. Treatment …  Best option TBD  No vaccine as of yet  No “gold standard” test  Clinical trials underway For mild cases:  Vital monitoring (temp, HR)  Hydration/electrolytes  Light exercise (1MET or RPE 1-3/10)  Adequate rest  Anti-inflammatory diet  Scrubbing of hands 15-20sec Fun fact: coronaviruses do not like *Heat and UV rays* hence the reason for “flu season” occurring in Winter not Summer.
  • 12. Why Light Exercise v My Normal?  Starting with elevated heart rate and likely impaired lung function  Impaired oxygenation to body  Abnormal heart rhythm  Normal strength training (60-80% max effort) works to breakdown muscle systems  Spreading work capacity to heal body  Inc/restart inflammatory response  Work lower extremity vs upper extremity  Less HR and BP changes
  • 14. Citations 1. Coronavirus | Human Coronavirus Types | CDC. https://www.cdc.gov/coronavirus/types.html. Published February 27, 2020. Accessed April 18, 2020. 2. Fehr AR, Perlman S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Coronaviruses. 2015;1282:1-23. doi:10.1007/978-1-4939-2438-7_1 3. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. http://www.ncbi.nlm.nih.gov/books/NBK554776/. 4. Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak. The White House. https://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/. Accessed April 18, 2020. 1. 5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020. 1. 6. Coronavirus COVID-19 (SARS-CoV-2) | Johns Hopkins ABX Guide. https://www.hopkinsguides.com/hopkins/.//view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_?refer=true. Accessed April 18, 2020. 1. 7. Isolation Precautions | Guidelines Library | Infection Control | CDC. https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html. Published July 22, 2019. Accessed April 18, 2020. 1. 8. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology. 2004;203(2):631-637. doi:10.1002/path.15701. 9. The Renin-Angiotensin-Aldosterone-System - Renin Release - Angiotensin II Production. TeachMePhysiology. https://teachmephysiology.com/urinary- system/regulation/the-renin-angiotensin-aldosterone-system/. Accessed April 18, 2020. 1. 10. Twig Interactive L http://www twiginteractive com. Programs. Tarix Orphan. http://www.tarixorphan.com/programs/. Accessed April 18, 2020. 11. (422) Vital Signs, Oxygen, & Exercise Prescription. How are these impacted by COVID-19 By Ellen Hillegass - YouTube. https://www.youtube.com/watch?v=lj716KWNcig. Accessed April 18, 2020. 1. 12. Papinska AM, Soto M, Meeks CJ, Rodgers KE. Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling. Pharmacol Res. 2016;107:372-380. doi:10.1016/j.phrs.2016.02.0261. 13. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. New England Journal of Medicine. 2020;0(0):null. doi:10.1056/NEJMsr2005760

Editor's Notes

  1. The current COVID-19 is a beta. Newest information is showing no bats within 30 miles of suspected transmission site of animal to human.
  2. COVID-19 demonstrated to be small enough in size to be passed through respiratory droplets while talking. Incubation = infectious period Shedding = production of virus within body Contact precautions: gloves and gown Droplet precautions: gloves, gown, eye protection, and surgical mask Airborne precautions: full body coverage + n95 mask (filters smaller particles)
  3. ACE2 receptors are the key on COVID-19 and the lock is all the receptors also found within the body, thus allowing it entry to many organs
  4. Down-regulation of ACE2 (angiotension converting enzyme 2) from COVID19. If you minimize function of ACE2 you get excess inflammation, water retention, fibrosis of tissues, etc.. Many MAS receptors are located in lungs, brain, heart, bone marrow, muscle
  5. ACE2 down regulation therefore begins to affect multiple organs and shuts off the gate keeper mentality of the RAAS system. This is why you hear of “multi-organ failure” Shortness of breath/cough/inc respiratory rate/pneumonia/dec oxygenation due to ACE2 attacking the respiratory cells of the lung and essentially inactivating them. Renal failure due to dec renal perfusion and therefore acute kidney injury begins to cause failure from continued inhibition and no release of renin Diarrhea due to ACE2 receptors located in intestine, inc inflammation/dilation/water retention in intestine thus loose stool Myalgia due to ACE2 receptors located in bone marrow and muscle Fever/headache due to ACE2 receptors located in brain/vessel smooth muscle and the rapid cascade of inflammatory proteins
  6. Peak function of the body in all its components without external variables is 25-35 years of age. Therefore as you age, natural processes takes course and the body begins to not work at full optimal capacity. Diabetes is directly related to the RAAS system and therefore poses the largest risk for individuals. Any disease or poor function of the organs involved with the RAAS system are therefore at a risk. Autoimmune diseases are malfunction of the immune system thereby dec ability to fight off infection. Lack of money to afford safe living, medical care, access to news/information on health. Rural living might have similar issues and/or lack of expertise to treat diagnoses. Social support needed for mental health and well-being. Family/roommates pose health risk as they may be symptomatic or asymptomatic carriers.
  7. 3 METS = walking up flight of stairs RPE scale: 1- rest 3- carry on conversation 5- breath halfway thru sentence 7- difficult to say more than a word a breath 10- gassed out/maximal effort Check wrist pulse: put thumb and ring finger together then bend wrist palm toward arm, find tendons just under wrist crease, move just outside tendons (under thumb) and press lightly with fingertips. Check pulse for 20-30sec duration to ensure no abnormal rhythm. (60-80 normal for healthy mid-aged adult)
  8. If you are perfectly healthy your body spends 100% time to keep it that way. Now you have an illness. 50% time to fighting illness, 50% time to normal function of body. Now add intense exercise breaking down muscle to rebuild: 30% time on building muscle, 30% fighting illness, 30% normal function of body. Now add comorbidities (smoker, hypertension, anemic, etc.) You get the picture… Normal breathing: inhale 1 sec, exhale 2 sec Breathing exercise: sitting tall, inhale thru nose for 1 sec, hold for 3-5 sec, exhale thru mouth as if to blow out a candle for as long as possible